PRKAA2 and rhabdomyosarcoma: Thus, models with concurrent knockout of both AMPKα isoforms should provide a definite answer as to whether AMPK signaling might promote rhabdomyosarcoma multidrug resistance by regulating mitochondrial dynamics.